The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement

PURPOSE: To provide consensus recommendations on the use of epidermal growth factor receptor tyrosine kinase inhibitors (egfr-tkis) in patients with advanced or meta-static non-small-cell lung cancer (nsclc). METHODS: Using a systematic literature search, phase ii trials, randomized phase iii trials...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ellis, P.M., Morzycki, W., Melosky, B., Butts, C., Hirsh, V., Krasnoshtein, F., Murray, N., Shepherd, F.A., Soulieres, D., Tsao, M.S., Goss, G.
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc. 2009
Matèries:
Practice Guideline Series
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2644627/
https://ncbi.nlm.nih.gov/pubmed/19229369
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars